Suchergebnisse - "Guo, Qinglong"

PubPharm (480)

81

Application of GL-V9 in preparation of anti-glioma drugs

enthalten in: Europäisches Patentamt | 2021

von GUO QINGLONG | HUI HUI | LI HUI | +7

82

Application of GL-V9 as tumor immunomodulator

enthalten in: Europäisches Patentamt | 2021

von GUO QINGLONG | HUI HUI | LI HUI | +7

83

Application of flavonoid derivative CPU-008 in preparation of anti-acute myeloid leukemia medicine

enthalten in: Europäisches Patentamt | 2021

von GUO QINGLONG | HUI HUI | LI HUI | +7

84

Application of GL-V9 in preparation of anti-melanoma drugs

enthalten in: Europäisches Patentamt | 2021

von GUO QINGLONG | HUI HUI | LI HUI | +7

85

Oroxylin and docetaxel combined anti-tumor drug and application thereof

enthalten in: Europäisches Patentamt | 2021

von GUO QINGLONG | WEI LIBIN | ZHAO LI | +4

86

Oroxylin and sorafenib combined anti-tumor drug and application thereof

enthalten in: Europäisches Patentamt | 2021

von GUO QINGLONG | WEI LIBIN | GAO YUAN | +4

87

Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia

enthalten in: Cell communication and signaling : CCS | 2021

von Qing, Y. | Wang, X. | Wang, H. | +9

88

Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia

enthalten in: Cell communication and signaling | 2021

von Qing, Y. | Wang, X. | Wang, H. | +9

89

AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p

enthalten in: Cellular signalling | 2021

von Pan, D. | Yang, W. | Zeng, Y. | +6

90

Application of GL-V9 in preparation of medicine for preventing and/or treating hepatic fibrosis

enthalten in: Europäisches Patentamt | 2021

von ZHAO LI | GUO YABING | XU SHENGYAO | +1